Jing Yi Wang
Direktor/Vorstandsmitglied bei SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
Vermögen: 123 Mio $ am 30.04.2024
Aktive Positionen von Jing Yi Wang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. | Direktor/Vorstandsmitglied | 22.11.2016 | - |
Karriereverlauf von Jing Yi Wang
Ehemalige bekannte Positionen von Jing Yi Wang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SICHUAN KELUN PHARMACEUTICAL CO., LTD. | Direktor/Vorstandsmitglied | 16.09.2015 | 01.02.2021 |
| Corporate Officer/Principal | 17.11.2012 | 01.02.2021 | |
| University of Arkansas for Medical Sciences | Corporate Officer/Principal | 01.12.1999 | 01.03.2001 |
Qilu Pharmaceutical Co., Ltd.
 Qilu Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Qilu Pharmaceutical Co., Ltd. manufactures and markets generic drugs. It offers services in the areas of oncology, infections, cerebrovascular and cardiovascular, psychological and neurological system, respiratory system and ophthalmological diseases. The company was founded in 1958 and is headquartered in Jinan, China. | Corporate Officer/Principal | - | - |
Ausbildung von Jing Yi Wang
| China Medical University | Undergraduate Degree |
| Fourth Military Medical University | Graduate Degree |
Statistik
International
| China | 5 |
| Vereinigte Staaten | 2 |
| 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SICHUAN KELUN PHARMACEUTICAL CO., LTD. | Health Technology |
| SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Qilu Pharmaceutical Co., Ltd.
Qilu Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Qilu Pharmaceutical Co., Ltd. manufactures and markets generic drugs. It offers services in the areas of oncology, infections, cerebrovascular and cardiovascular, psychological and neurological system, respiratory system and ophthalmological diseases. The company was founded in 1958 and is headquartered in Jinan, China. | Health Technology |
- Börse
- Insiders
- Jing Yi Wang
- Erfahrung
